149 related articles for article (PubMed ID: 34478717)
1. Flow cytometry as a diagnostic tool in neuroblastoma.
Furlanetto G; Spagnol F; Alegretti AP; Farias MG; Soares VJ; Daudt LE; Loss JF; Scroferneker ML; Michalowski MB
J Immunol Methods; 2021 Nov; 498():113135. PubMed ID: 34478717
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants.
Dondero A; Morini M; Cangelosi D; Mazzocco K; Serra M; Spaggiari GM; Rotta G; Tondo A; Locatelli F; Castellano A; Scuderi F; Sementa AR; Eva A; Conte M; Garaventa A; Bottino C; Castriconi R
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795387
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of initial bone marrow disease detection by multiparameter flow cytometry in children with neuroblastoma.
Popov A; Druy A; Shorikov E; Verzhbitskaya T; Solodovnikov A; Saveliev L; Tytgat GAM; Tsaur G; Fechina L
J Cancer Res Clin Oncol; 2019 Feb; 145(2):535-542. PubMed ID: 30603901
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric analysis of peripheral blood and bone marrow for tumor cells in patients with neuroblastoma.
Komada Y; Zhang XL; Zhou YW; Inaba H; Deguchi T; Azuma E; Sakurai M
Cancer; 1998 Feb; 82(3):591-9. PubMed ID: 9452279
[TBL] [Abstract][Full Text] [Related]
5. Combined use of multiparametric flow cytometry and cytomorphology to enhance detection of neuroblastoma metastatic cells in bone marrow.
Manenq C; Lesesve JF; Dreumont N; Massin F; Salignac S; Mansuy L; Chastagner P; Latger-Cannard V; Broséus J
Int J Lab Hematol; 2020 Feb; 42(1):52-60. PubMed ID: 31821742
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic value of bone marrow lesions in children with neuroblastoma detected by flow cytometry].
Popov AM; Shorikov EV; Verzhditskaia TIu; Tsaur GA; Druĭ AE; Solodovnikov AG; Savel'ev LI; Fechina LG
Vopr Onkol; 2014; 60(4):469-75. PubMed ID: 25552066
[TBL] [Abstract][Full Text] [Related]
7. Comparative Analysis of Flow Cytometry and Cytomorphology for Neuroblastoma Cell Detection in Effusion and Bone Marrow Specimens.
Ye W; Wang J; Li W; Shen H
Fetal Pediatr Pathol; 2019 Feb; 38(1):1-7. PubMed ID: 30667298
[TBL] [Abstract][Full Text] [Related]
8. Comparative Analysis of Multicolor Flow Cytometry and Immunohistochemistry for the Detection of Disseminated Tumor Cells.
Szánthó E; Kárai B; Ivády G; Bedekovics J; Szegedi I; Petrás M; Ujj G; Ujfalusi A; Kiss C; Kappelmayer J; Hevessy Z
Appl Immunohistochem Mol Morphol; 2018; 26(5):305-315. PubMed ID: 28426528
[TBL] [Abstract][Full Text] [Related]
9. TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients.
Yáñez Y; Hervás D; Grau E; Oltra S; Pérez G; Palanca S; Bermúdez M; Márquez C; Cañete A; Castel V
J Cancer Res Clin Oncol; 2016 Mar; 142(3):573-80. PubMed ID: 26498952
[TBL] [Abstract][Full Text] [Related]
10. Potential application of ELAVL4 real-time quantitative reverse transcription-PCR for detection of disseminated neuroblastoma cells.
Swerts K; De Moerloose B; Dhooge C; Vandesompele J; Hoyoux C; Beiske K; Benoit Y; Laureys G; Philippé J
Clin Chem; 2006 Mar; 52(3):438-45. PubMed ID: 16384890
[TBL] [Abstract][Full Text] [Related]
11. Prognostic influence of minimal residual disease detected by flow cytometry and peripheral blood stem cell transplantation by CD34+ selection in childhood advanced neuroblastoma.
Cai JY; Tang YJ; Jiang LM; Pan C; Chen J; Tang JY
Pediatr Blood Cancer; 2007 Dec; 49(7):952-7. PubMed ID: 17514736
[TBL] [Abstract][Full Text] [Related]
12. Minimal disease detection in peripheral blood and bone marrow from patients with non-metastatic neuroblastoma.
Yáñez Y; Grau E; Oltra S; Cañete A; Martínez F; Orellana C; Noguera R; Palanca S; Castel V
J Cancer Res Clin Oncol; 2011 Aug; 137(8):1263-72. PubMed ID: 21706131
[TBL] [Abstract][Full Text] [Related]
13. High-sensitivity immunocytologic analysis of neuroblastoma cells in paired blood and marrow samples.
Faulkner LB; Tintori V; Tamburini A; Paoli A; Garaventa A; Viscardi E; Tucci F; Lippi AA; De Bernardi B; Bernini G
J Hematother; 1998 Aug; 7(4):361-6. PubMed ID: 9735867
[TBL] [Abstract][Full Text] [Related]
14. mRNAs of tyrosine hydroxylase and dopa decarboxylase but not of GD2 synthase are specific for neuroblastoma minimal disease and predicts outcome for children with high-risk disease when measured at diagnosis.
Träger C; Vernby A; Kullman A; Ora I; Kogner P; Kågedal B
Int J Cancer; 2008 Dec; 123(12):2849-55. PubMed ID: 18814238
[TBL] [Abstract][Full Text] [Related]
15. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
[TBL] [Abstract][Full Text] [Related]
16. Molecular detection of dopamine decarboxylase expression by means of reverse transcriptase and polymerase chain reaction in bone marrow and peripheral blood: utility as a tumor marker for neuroblastoma.
Bozzi F; Luksch R; Collini P; Gambirasio F; Barzanò E; Polastri D; Podda M; Brando B; Fossati-Bellani F
Diagn Mol Pathol; 2004 Sep; 13(3):135-43. PubMed ID: 15322424
[TBL] [Abstract][Full Text] [Related]
17. Detection of neuroblastoma cells during clinical follow up: advanced flow cytometry and rt-PCR for tyrosine hydroxylase using both conventional and real-time PCR.
Esser R; Glienke W; Bochennek K; Erben S; Quaiser A; Pieper C; Eggert A; Schramm A; Astrahantseff K; Hansmann ML; Schwabe D; Klingebiel T; Koehl U
Klin Padiatr; 2011 Nov; 223(6):326-31. PubMed ID: 22095188
[TBL] [Abstract][Full Text] [Related]
18. Contribution of multiparameter flow cytometry immunophenotyping to the diagnostic screening and classification of pediatric cancer.
Ferreira-Facio CS; Milito C; Botafogo V; Fontana M; Thiago LS; Oliveira E; da Rocha-Filho AS; Werneck F; Forny DN; Dekermacher S; de Azambuja AP; Ferman SE; de Faria PA; Land MG; Orfao A; Costa ES
PLoS One; 2013; 8(3):e55534. PubMed ID: 23472067
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric phenotype of rhabdomyosarcoma bone marrow metastatic cells and its implication in differential diagnosis with neuroblastoma.
Bozzi F; Collini P; Aiello A; Barzanò E; Gambirasio F; Podda M; Meazza C; Ferrari A; Luksch R
Anticancer Res; 2008; 28(3A):1565-9. PubMed ID: 18630512
[TBL] [Abstract][Full Text] [Related]
20. Detection of residual neuroblastoma cells in bone marrow: comparison of flow cytometry with immunocytochemistry.
Swerts K; De Moerloose B; Dhooge C; Brichard B; Benoit Y; Laureys G; Philippé J
Cytometry B Clin Cytom; 2004 Sep; 61(1):9-19. PubMed ID: 15351977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
